logo
Office microwaves could be cooking up more than just leftovers, study suggests

Office microwaves could be cooking up more than just leftovers, study suggests

Fox News24-03-2025

A study about office microwaves may have some people rethinking their leftovers for lunch.
Researchers examined the differences in bacteria present in domestic spaces such as a home; in shared-domestic spaces such as an office; and in laboratories.
The study, conducted by researchers in Valencia, Spain, and published in Frontiers in Microbiology, discovered over 100 species of bacteria exist within these spaces – with most of the bacteria being the types found on human skin.
Some of these bacteria can cause foodborne illnesses.
Fox News Digital spoke with Christine Schindler, the New York City-based CEO and co-founder of PathSpot, a health and safety operating system for restaurants and businesses that prepare and serve food, about the difference between at-home and in-office appliances.
"The setting of a microwave fundamentally changes its contamination profile," she told Fox News Digital.
"People rush through lunch breaks, sometimes skipping proper hand hygiene, touching communal surfaces like refrigerator handles before accessing the microwave," she added.
In shared environments like this, microwaves can become bacterial transfer points, she said.
These different bacteria can come from human skin, food splatter and moisture build-up.
Microwaves can become bacterial transfer points.
The presence of bacteria can cause stomach problems such as nausea and vomiting – and the risk increases through the "food-handling sequence," according to Schindler.
"Bacterial risk isn't just about what grows in the microwave – it's about how bacteria move between hands, surfaces and food in a continuous cycle," Schindler said.
Something else the researchers sought to understand is whether microwave radiation has a sterilizing effect on food or if exposure to a wide variety of food and humans had more impact on cleanliness.
"Microwaves kill bacteria in food through heat, not the actual microwaves themselves," Schindler clarified.
"However, this heating doesn't clean the microwave itself or address the bacteria on handles and buttons from unwashed hands," she said.
"This creates a shared responsibility in food safety – you need both properly cooked food and clean microwave surfaces to break the contamination cycle."
The researchers said that what they found "suggests the importance of regular cleaning practices to mitigate potential health risks, as frequent and adequate cleaning with appropriate disinfectants helps to prevent the presence of pathogens associated with these domestic environments."
At home, you're typically dealing with a known group of users and established cleaning routines, something Schindler said makes the difference in maintaining a hygienic environment.
"Office break rooms create more opportunities for bacterial spread," she said. "More users means more hand-to-surface contamination, often less personal accountability for cleaning and greater diversity of foods being heated."
There are some simple ways to keep microwaves clean, even in the office.
Schindler said to wipe down these high-touch areas regularly with food-safe disinfectants, especially in shared kitchens where many people use the same appliance.
For those with more time to spare, she said, heating a bowl of water with lemon juice can loosen up any gunk inside the microwave, making removal easier.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

AstraZeneca announces results from MATTERHORN Phase III trial of IMFINZI
AstraZeneca announces results from MATTERHORN Phase III trial of IMFINZI

Business Insider

time5 hours ago

  • Business Insider

AstraZeneca announces results from MATTERHORN Phase III trial of IMFINZI

Positive results from the MATTERHORN Phase III trial showed perioperative treatment with AstraZeneca's (AZN) IMFINZI in combination with standard-of-care FLOT chemotherapy demonstrated a statistically significant and clinically meaningful improvement in the primary endpoint of event-free survival, EFS, versus chemotherapy alone. Patients were treated with neoadjuvant IMFINZI in combination with chemotherapy before surgery, followed by adjuvant IMFINZI in combination with chemotherapy, then IMFINZI monotherapy. The trial evaluated this regimen versus perioperative chemotherapy alone for patients with resectable, early-stage and locally advanced gastric and gastroesophageal junction, GEJ, cancers. In a planned interim analysis, patients treated with the IMFINZI-based perioperative regimen showed a 29% reduction in the risk of disease progression, recurrence or death versus chemotherapy alone. Estimated median EFS was not yet reached for the IMFINZI arm versus 32.8 months for the comparator arm. For the secondary endpoint of overall survival, a strong trend was observed in favor of the IMFINZI-based perioperative regimen. The trial will continue to follow OS, which will be formally assessed at the final analysis. Confident Investing Starts Here:

Guardant Health presented results of largest study on ctDNA in colon cancer
Guardant Health presented results of largest study on ctDNA in colon cancer

Business Insider

time5 hours ago

  • Business Insider

Guardant Health presented results of largest study on ctDNA in colon cancer

Guardant Health (GH) presented results of the largest study to date evaluating circulating tumor DNA, ctDNA, in colon cancer prior to chemotherapy, demonstrating the ability of the Guardant Reveal test to stratify the risk of disease recurrence and overall survival, and thus inform treatment decisions after surgery. Data from the phase III trial of FOLFOX-based adjuvant chemotherapy involving over 2,000 patients with stage III colon cancer with median follow-up of 6.1 years were presented at the 2025 American Society for Clinical Oncology Annual Meeting. Results demonstrated that circulating tumor DNA detected in the bloodstream after cancer surgery and prior to the start of adjuvant therapy, using the Guardant Reveal test, is a strong predictor of the risk of disease recurrence and poorer survival, and suggest the potential for ctDNA testing to improve decision-making at a critical time point for post-operative chemotherapy. Specifically: Among patients with post-surgical ctDNA detected, 62.6% had the cancer return within 3 years, despite having had adjuvant chemotherapy, while only 15.4% of patients with undetectable ctDNA recurred in the same period. The level of ctDNA, or tumor fraction, showed promise in identifying individuals who are less likely to clear residual disease with adjuvant treatment.

Black Book Research Names 2025's Top Vendors in Risk Adjustment & Coding Optimization for Health Plans and Payers
Black Book Research Names 2025's Top Vendors in Risk Adjustment & Coding Optimization for Health Plans and Payers

Associated Press

time6 hours ago

  • Associated Press

Black Book Research Names 2025's Top Vendors in Risk Adjustment & Coding Optimization for Health Plans and Payers

Advanced Analytics, AI, and Automation Become Essential as Payers Face Increased Scrutiny on Risk Adjustment Accuracy and Financial Performance NEW YORK CITY, NY / ACCESS Newswire / June 1, 2025 / As healthcare payers face intensified regulatory oversight, rising healthcare costs, and the evolving complexities of risk adjustment, Black Book Research today announced its 2025 rankings of the leading vendors in Risk Adjustment & Coding Optimization software. These solutions have become essential for payers seeking accurate, compliant, and financially optimized coding practices across Medicare Advantage, Medicaid managed care, ACA marketplace plans, and commercial insurers. According to Black Book's latest payer survey conducted between Q4 2024 and Q1 2025, with responses from 1,108 senior payer executives, finance officers, and risk adjustment leaders, 92% indicated that advanced analytics and artificial intelligence (AI) tools are now critical for accurate risk scoring, improved coding efficiency, and maintaining regulatory compliance. 'Health plans are urgently investing in technology solutions that provide precise, predictive, and fully compliant risk adjustment and coding practices,' said Doug Brown, President of Black Book Research. 'Optimized coding not only ensures regulatory compliance but significantly impacts financial stability, resource allocation, and member care quality.' Scope and Opportunity in Risk Adjustment & Coding Optimization Software The survey highlights a growing emphasis on several core areas where payer software solutions can dramatically enhance performance: Accurate Risk Scoring: 94% of respondents highlighted accuracy in HCC (Hierarchical Condition Categories) and RAF (Risk Adjustment Factor) scoring as their highest priority. Regulatory Compliance: 89% emphasized the importance of software capable of continuous compliance monitoring, automated audits, and coding validation. Predictive Analytics: 87% of payers prioritize advanced analytics solutions that anticipate risk and allow proactive management of populations. Automated Coding Processes: 70% noted the necessity for automation to reduce manual errors, streamline workflows, and accelerate coding accuracy. Interoperability and Data Integration: 66% reported interoperability as essential, ensuring seamless data flow among providers, payers, and regulatory bodies. Top 10 Vendors in Risk Adjustment & Coding Optimization (Ranked by Client Satisfaction and Performance) Edifecs - Distinguished for its robust interoperability solutions and real-time risk adjustment analytics that streamline payer workflows and ensure regulatory accuracy. Apixio - Recognized for its AI-powered risk adjustment analytics, utilizing natural language processing (NLP) to dramatically improve coding accuracy and risk stratification. SCIO Health Analytics (EXL) - Highly rated for predictive modeling and comprehensive analytics tools that significantly enhance coding accuracy, financial forecasting, and compliance management. Advantasure - Praised for its integrated risk adjustment platform, offering real-time analytics, automated chart reviews, and predictive risk identification. Change Healthcare - Valued for sophisticated coding optimization and analytics capabilities, significantly reducing audit risks and improving revenue accuracy. Innovaccer - Noted for advanced analytics and integrated workflows that seamlessly connect payer data streams, optimizing risk management strategies. Inovalon - Applauded for scalable analytics platforms and comprehensive interoperability, enhancing accuracy in risk scoring and regulatory compliance. Cotiviti - Recognized for its deep analytics and precise data validation, enabling payers to accurately capture risk and streamline coding compliance. Optum - Acknowledged for robust AI-driven risk adjustment and coding tools that integrate seamlessly across payer systems, delivering accuracy and compliance. Talix - Renowned for its innovative NLP-driven risk adjustment solutions that ensure precise coding, reducing compliance risk and maximizing revenue integrity. 'Risk adjustment and coding optimization software has become a strategic imperative for payers aiming to thrive in today's regulatory and competitive healthcare environment,' added Brown. 'Leveraging these technologies positions payers not only to achieve compliance but to realize substantial improvements in financial outcomes, operational efficiency, and member health management.' About Black Book Research Black Book Research provides unbiased, crowd-sourced insights into healthcare technology, services, and outsourcing. Since 2004, Black Book has surveyed over 1 million healthcare technology users and buyers, maintaining strict independence without vendor funding, advisory subscriptions, or performance improvement arrangements. To license the full complete 2025 Risk Adjustment & Coding Optimization report and detailed vendor performance metrics, visit: Media Inquiries: Email: [email protected] Contact Information Press Office [email protected] 8008637590 SOURCE: Black Book Research press release

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store